165 related articles for article (PubMed ID: 7493940)
21. Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site.
de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
Oncogene; 1997 Feb; 14(5):507-13. PubMed ID: 9053848
[TBL] [Abstract][Full Text] [Related]
22. A 41-kilodalton protein is a potential substrate for the p210bcr-abl protein-tyrosine kinase in chronic myelogenous leukemia cells.
Freed E; Hunter T
Mol Cell Biol; 1992 Mar; 12(3):1312-23. PubMed ID: 1545812
[TBL] [Abstract][Full Text] [Related]
23. Cellular interactions of CRKL, and SH2-SH3 adaptor protein.
ten Hoeve J; Kaartinen V; Fioretos T; Haataja L; Voncken JW; Heisterkamp N; Groffen J
Cancer Res; 1994 May; 54(10):2563-7. PubMed ID: 8168080
[TBL] [Abstract][Full Text] [Related]
24. Cell-penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients.
Kardinal C; Konkol B; Schulz A; Posern G; Lin H; Adermann K; Eulitz M; Estrov Z; Talpaz M; Arlinghaus RB; Feller SM
FASEB J; 2000 Aug; 14(11):1529-38. PubMed ID: 10928987
[TBL] [Abstract][Full Text] [Related]
25. Detection in primary chronic myeloid leukaemia cells of p210BCR-ABL1 in complexes with adaptor proteins CBL, CRKL, and GRB2.
Patel H; Marley SB; Gordon MY
Genes Chromosomes Cancer; 2006 Dec; 45(12):1121-9. PubMed ID: 16955467
[TBL] [Abstract][Full Text] [Related]
26. In vivo regulation of CrkII and CrkL proto-oncogenes in the uterus by insulin-like growth factor-I. Differential effects on tyrosine phosphorylation and association with paxillin.
Butler AA; Blakesley VA; Koval A; deJong R; Groffen J; LeRoith D
J Biol Chem; 1997 Oct; 272(44):27660-4. PubMed ID: 9346905
[TBL] [Abstract][Full Text] [Related]
27. A specific need for CRKL in p210BCR-ABL-induced transformation of mouse hematopoietic progenitors.
Seo JH; Wood LJ; Agarwal A; O'Hare T; Elsea CR; Griswold IJ; Deininger MW; Imamoto A; Druker BJ
Cancer Res; 2010 Sep; 70(18):7325-35. PubMed ID: 20807813
[TBL] [Abstract][Full Text] [Related]
28. Structural requirements for function of the Crkl adapter protein in fibroblasts and hematopoietic cells.
Senechal K; Heaney C; Druker B; Sawyers CL
Mol Cell Biol; 1998 Sep; 18(9):5082-90. PubMed ID: 9710592
[TBL] [Abstract][Full Text] [Related]
29. Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1).
Sattler M; Salgia R; Shrikhande G; Verma S; Uemura N; Law SF; Golemis EA; Griffin JD
J Biol Chem; 1997 May; 272(22):14320-6. PubMed ID: 9162067
[TBL] [Abstract][Full Text] [Related]
30. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
Feller SM; Posern G; Voss J; Kardinal C; Sakkab D; Zheng J; Knudsen BS
J Cell Physiol; 1998 Dec; 177(4):535-52. PubMed ID: 10092207
[TBL] [Abstract][Full Text] [Related]
31. Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation.
Heaney C; Kolibaba K; Bhat A; Oda T; Ohno S; Fanning S; Druker BJ
Blood; 1997 Jan; 89(1):297-306. PubMed ID: 8978305
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Grb2 and Crkl proteins results in growth inhibition of Philadelphia chromosome positive leukemic cells.
Tari AM; Arlinghaus R; Lopez-Berestein G
Biochem Biophys Res Commun; 1997 Jun; 235(2):383-8. PubMed ID: 9199202
[TBL] [Abstract][Full Text] [Related]
33. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.
Okuda K; Golub TR; Gilliland DG; Griffin JD
Oncogene; 1996 Sep; 13(6):1147-52. PubMed ID: 8808688
[TBL] [Abstract][Full Text] [Related]
34. SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL.
Sattler M; Verma S; Pride YB; Salgia R; Rohrschneider LR; Griffin JD
J Biol Chem; 2001 Jan; 276(4):2451-8. PubMed ID: 11031258
[TBL] [Abstract][Full Text] [Related]
35. Detection of P210bcr-abl in mature granulocytes from Ph1-positive chronic myelogenous leukemia patients by an immunoblotting method.
Kuwao F; Takahashi I
Leukemia; 1993 Aug; 7(8):1168-73. PubMed ID: 8350617
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of c-Crk II on the negative regulatory Tyr222 mediates nerve growth factor-induced cell spreading and morphogenesis.
Escalante M; Courtney J; Chin WG; Teng KK; Kim JI; Fajardo JE; Mayer BJ; Hempstead BL; Birge RB
J Biol Chem; 2000 Aug; 275(32):24787-97. PubMed ID: 10825157
[TBL] [Abstract][Full Text] [Related]
37. CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk.
Oda A; Ochs HD; Lasky LA; Spencer S; Ozaki K; Fujihara M; Handa M; Ikebuchi K; Ikeda H
Blood; 2001 May; 97(9):2633-9. PubMed ID: 11313252
[TBL] [Abstract][Full Text] [Related]
38. The CRKL adaptor protein transforms fibroblasts and functions in transformation by the BCR-ABL oncogene.
Senechal K; Halpern J; Sawyers CL
J Biol Chem; 1996 Sep; 271(38):23255-61. PubMed ID: 8798523
[TBL] [Abstract][Full Text] [Related]
39. A novel 53 kDa protein complexed with P210bcr-abl in human chronic myelogenous leukemia cells.
Li WJ; Kloetzer WS; Arlinghaus RB
Oncogene; 1988 Jun; 2(6):559-66. PubMed ID: 3133627
[TBL] [Abstract][Full Text] [Related]
40. Phosphotyrosine phosphatase activity prevents the detection of P210bcr/abl protein in mature cells in chronic myelogenous leukemia even by an immunoblotting technique.
Shibata K; Nishimura J; Takahira H; Nawata H
Leukemia; 1989 Sep; 3(9):615-9. PubMed ID: 2474729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
